Acadia Pharmaceuticals insider trades
as of filings through Oct 30, 2026
- Bought
- $0
- 0 trades, 0 insiders
- Sold
- $69K
- 1 trade, 1 insider
- Net
- −$69K
- since Oct 30, 2026
- Under 10b5-1 plans
- 0
- of 1 sale
FiledStockInsiderSideValueSharesAvg priceTraded
- Filed Oct 30, 8:20 PM (the Form 4 at the SEC), traded Oct 30ACADSoldMark C. Schneyer · EVP, Chief Financial Officer$69.3K
More on ACAD
ACAD against its rivals
No comparison pages for ACAD.